CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30

CARDINAL HEALTH INC

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 11, 2026

$252.65−1.41 (-0.55%)

Close on Oct 19, 2026

Market cap: $59.12B
P/E (TTM): 34.9
Dividend yield: 0.81%

CARDINAL HEALTH INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-06-30	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30	FY 2020 2020-06-30	FY 2019 2019-06-30	FY 2018 2018-06-30	FY 2017 2017-06-30	FY 2016 2016-06-30	FY 2015 2015-06-30	FY 2014 2014-06-30	FY 2013 2013-06-30	FY 2012 2012-06-30	FY 2011 2011-06-30	FY 2010 2010-06-30	FY 2009 2009-06-30	FY 2008 2008-06-30
Revenue	254,248	222,578	226,827	204,979	181,326	162,467	152,922	145,534	136,809	129,976	121,546	102,531	91,084	101,093	107,552	102,644	98,503	95,992	87,408
Cost of Revenue	244,474	214,410	219,413	198,105	174,842	155,689	146,054	138,700	129,628	123,432	115,003	96,819	85,923	96,172	103,011	98,482	94,722	92,244	83,631
Gross Profit	9,774	8,168	7,414	6,874	6,484	6,778	6,868	6,834	7,181	6,544	6,543	5,712	5,161	4,921	4,541	4,162	3,781	3,748	3,777
Selling, General & Admin	6,132	5,382	5,000	4,800	4,512	4,533	4,572	4,480	4,596	3,775	3,648	3,240	3,028	2,875	2,677	2,528	2,397	2,334	2,341
Operating Income	2,613	2,275	1,243	752	-607	472	-4,098	2,060	126	2,120	2,459	2,161	1,885	996	1,792	1,514	1,307	1,287	1,392
Interest Expense	348	215	51	84	147	180	238	294	329	201	178	141	133	123	95	93	113	114	136
Income from Equity Investments	–	–	–	–	–	–	2.00	10	–	–	–	–	–	–	–	–	–	–	–
Other Non-Operating Income	31	41	9.00	-5.00	-22	47	1.00	-15	-23	5.00	-5.00	7.00	46	15	1.00	22	13	-13	39
Merger & Restructuring Charges	106	88	175	95	101	114	122	125	176	56	25	44	31	71	21	15	91	105	55
Asset Impairment Charges	184	–	675	1,227	2,084	0	0	0	1,400	–	–	829	829	829	–	0	18	0	–
Gain (Loss) on Investments	–	–	0	0	2.00	-2.00	579	0	–	–	–	–	–	0	0	75	45	0	0
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	23
Legal Settlements	10	185	-78	304	-94	-1,129	-5,741	-36	-159	-48	69	-5.00	21	38	3.00	-6.00	62	-5.20	-20
Pretax Income	2,174	2,101	1,201	663	-784	323	-3,772	1,751	-228	1,924	2,276	1,967	1,798	888	1,698	1,518	1,212	1,160	1,295
Income Tax Expense	469	532	348	332	153	-289	-79	386	-487	630	845	755	635	553	628	552	625	402	448
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	1,288	1,427	1,212	1,163	335	1,070	966	587	758	847
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	0	0	3.00	3.00	-1.00	-1.00	-7.00	55	393	453
Net Income incl. Noncontrolling Interests	1,705	1,569	853	331	-937	612	-3,693	1,365	259	1,294	1,431	1,215	1,166	–	–	–	–	–	–
Minority Interest in Earnings	-9.00	8.00	1.00	1.00	1.00	1.00	3.00	2.00	3.00	6.00	4.00	0	0	–	–	–	–	–	–
Net Income	1,714	1,561	852	330	-938	611	-3,696	1,363	256	1,288	1,427	1,215	1,166	334	1,069	959	642	1,152	1,301
EPS (Basic)(per share)	7.27	6.48	3.48	1.27	-3.37	2.09	-12.61	4.55	0.82	4.06	4.36	3.66	3.42	0.98	3.10	2.75	1.79	3.22	–
EPS (Diluted)(per share)	7.23	6.45	3.45	1.26	-3.37	2.08	-12.61	4.53	0.81	4.03	4.32	3.62	3.38	0.97	3.06	2.72	1.77	3.18	–
Shares Outstanding (Basic, Weighted)(shares)	236	241	245	261	279	292	293	300	313	317	327	332	341	341	345	349	359	358	358
Shares Outstanding (Diluted, Weighted)(shares)	237	242	247	262	279	294	293	301	315	320	330	335	345	344	349	353	361	362	364
Dividend per Share(per share)	2.04	2.02	2.00	1.98	1.96	1.94	1.92	1.91	1.85	1.80	1.55	1.37	1.21	1.03	0.86	0.78	0.70	0.56	0.48
EBITDA	3,569	3,065	1,953	1,444	85	1,255	-3,185	3,060	1,158	2,837	3,100	2,612	2,344	1,393	2,117	1,827	1,561	1,513	1,612

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 3.8%
Operating margin: 1.0%
Net margin: 0.7%
Return on equity, FY2026: -60.5%

Financial strength

Current ratio: 0.88
Debt to equity: -3.08
Debt to assets: 15.5%
Cash to current liabilities: 11.1%

Valuation

P/E ratio: 34.9
Price to sales: 0.23
Price to book: –
Dividend yield: 0.81%